Marken launches container for cell and gene therapy shipment

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/metamorworks)
(Image: Getty/metamorworks)

Related tags: Marken, cell and gene therapy, Logistics

Marken introduces a container for shipments of clinical drug products, clinical drug substance, as well as cell and gene therapies.

Marken​, the clinical supply subsidiary of UPS, recently launched a custom-designed thermal box, which it touted as “the first truly configurable container capable of utilizing any GPS tracking device available today​.”

Marken’s Smart Box offers constant visibility of the cargo, providing information about location, temperature, movement, shock, pressure, and light. The container uses the company’s Sentry tracking device, while also accommodating Bluetooth technology for temperature monitoring and identification.

The container has been designed to maintain a stable temperature range of 2-8°C for up to 96 hours, though Marken aims to offer -20°C and 15-25°C services in the near future.

Cell and gene therapies are, by nature, very complex and require a narrow window for delivery,​” the spokesperson told us, stating that the shipments are irreplaceable, and therefore, need to remain secure.

According to the company, users will also have the choice to add a lock or security seal to each shipment.

As stated by Marken’s CEO, Wes Wheeler, at least 1,000 Smart Box containers are scheduled for delivery to various locations starting this month.

At the same time, the company plans to increase the number of Sentry GPS tracking devices within its inventory and has placed additional orders for thermal packaging to supplement the Smart Box.

According to the company, Marken manages 55,000 drug and biological shipments every month at all temperature ranges, in more than 150 countries.

An estimation about the company’s investment in the development of the Smart Box could not be disclosed.

Related news

Related products

show more

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Discover Fermion’s new API unit 4 in Hanko

Discover Fermion’s new API unit 4 in Hanko

Recorded the 04-Sep-2018 | Webinar

Join this webinar to learn more about Fermion’s new manufacturing unit 4 at the Hanko site. This webinar will provide virtual tour to our new state of...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars